<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bekhterev</journal-id><journal-title-group><journal-title xml:lang="ru">Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева</journal-title><trans-title-group xml:lang="en"><trans-title>V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7053</issn><issn pub-type="epub">2713-055X</issn><publisher><publisher-name>V. M. BEKHTEREV  NATIONAL  RESEARCH  MEDICAL  CENTER  FOR  PSYCHIATRY  AND  NEUROLOGY                           OF    THE  RUSSIAN  FEDERATION   MINISTRY  OF  HEALTH</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31363/2313-7053-2019-4-1-98-100</article-id><article-id custom-type="elpub" pub-id-type="custom">bekhterev-322</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЕ РАБОТЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH PAPERS</subject></subj-group></article-categories><title-group><article-title>Типы течения шизофрении и полиморфизмы генов нейрональных протеинкиназ  на модели PIP5K2A, GSK3B и AKT1</article-title><trans-title-group xml:lang="en"><trans-title>Type of course of schizophrenia and polymorphisms  of neuronal protein kinase genes  on the model of PIP5K2A, GSK3B and AKT1</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полтавская</surname><given-names>Е. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Poltavskaya</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">egboyarko@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федоренко</surname><given-names>О. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedorenko</surname><given-names>O. Y.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">f_o_y@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ психического здоровья Томского НИМЦ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mental Health Research Institute of Tomsk NRMC</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>НИИ психического здоровья Томского НИМЦ; Российский национальный консорциум по психиатрической генетике</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mental Health Research Institute of Tomsk NRMC</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>08</day><month>12</month><year>2019</year></pub-date><volume>0</volume><issue>4-1</issue><fpage>98</fpage><lpage>100</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Полтавская Е.Г., Федоренко О.Ю., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Полтавская Е.Г., Федоренко О.Ю.</copyright-holder><copyright-holder xml:lang="en">Poltavskaya E.G., Fedorenko O.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bekhterevreview.com/jour/article/view/322">https://www.bekhterevreview.com/jour/article/view/322</self-uri><abstract><p>Роль протеинкиназ при шизофрении активно изучается. Однако влияние полиморфизмов генов протеинкиназ на клинические проявления заболевания мало изучено. Было обследовано 384 пациента с диагнозом шизофрении в соответствии с МКБ-10 (F20) (269 пациентов с непрерывным течением шизофрении; 115 пациентов с эпизодическим течением болезни). Генотипирование полиморфизмов PIP5K2A (rs10828317, rs8341, rs746203), GSK3B (rs334558), AKT1 (rs3730358, rs1130214) проводилось методом ПЦР в реальном времени. Выявлена ассоциация rs8341 PIP5K2A с типом течением шизофрении. Генотип CT был ассоциирован с непрерывным типом течения шизофрении, генотип TT — с эпизодическим. Нарушения фосфоинозитидного пути могут быть возможной причиной перехода к более тяжелому непрерывному течению шизофрении.</p></abstract><trans-abstract xml:lang="en"><p>The role of protein kinases in schizophrenia is being actively studied. However, the effect of protein kinase gene polymorphisms on the clinical manifestations of the disease has been little studied. We examined 384 patients diagnosed with schizophrenia in accordance with ICD-10 (F20) (269 patients with a continuous course of schizophrenia; 115 patients with an episodic course of the disease). Genotyping of polymorphisms PIP5K2A (rs10828317, rs8341, rs746203), GSK3B (rs334558), AKT1 (rs3730358, rs1130214) was carried out by real-time PCR method. An association of rs8341 PIP5K2A with the type of course of schizophrenia was revealed. The CT genotype was associated with a continuous type of schizophrenia, the TT genotype with an episodic one. Disorders of the phosphoinositide pathway may be a possible cause of the transition to a more severe continuous course of schizophrenia.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>шизофрения</kwd><kwd>PIP5K2A</kwd><kwd>GSK3B</kwd><kwd>AKT1</kwd><kwd>полиморфизм гена</kwd></kwd-group><kwd-group xml:lang="en"><kwd>schizophrenia</kwd><kwd>PIP5K2A</kwd><kwd>GSK3B</kwd><kwd>AKT1</kwd><kwd>gene polymorphism</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Иванова С.А., Лосенков И.С., Бохан Н.А. Роль киназы гликогенсинтазы-3β в патогенезе психических расстройств. Журнал неврологии и психиатрии им. C.C. Корсакова. 2014;114(6):93100.</mixed-citation><mixed-citation xml:lang="en">Ivanova SA, Losenkov IS, Bokhan NA. Role of glycogen synthase kinase-3β in the pathogenesis of mental disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(6):93-100 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Лосенков И.С., Вялова Н.М., Симуткин Г.Г., Иванова С.А., Бохан Н.А. Полиморфизмы гена GSK3B при депрессивных расстройствах. Современные проблемы науки и образования. 2013;6.</mixed-citation><mixed-citation xml:lang="en">Losenkov IS, Vyalova NM, Simutkin GG, Ivanova SA, Bokhan NA. GSK3B gene polymorphism in depressive disorders. Modern problems of science and education. 2013;6. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorenko O, Rudikov EV, Gavrilova VA, Boiarko EG, Semke AV, Ivanova SA. Association of (N251S)-PIP5K2A with schizophrenic disorders: a study of the Russian population of Siberia. Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113:58–61.</mixed-citation><mixed-citation xml:lang="en">Fedorenko O, Rudikov EV, Gavrilova VA, Boiarko EG, Semke AV, Ivanova SA. Association of (N251S)-PIP5K2A with schizophrenic disorders: a study of the Russian population of Siberia. Zh Nevrol Psikhiatr Im S S Korsakova. 2013; 113:58–61.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorenko OY, Loonen AJ, Lang F, Toshchakova VA, Boyarko EG, Semke AV, et al. Association study indicates a protective role of phosphatidylinositol-4phosphate-5-kinase against tardive dyskinesia. Int J Neuropsychopharmacol. 2014;18(6). pii: pyu098. doi: 10.1093/ijnp/pyu098.</mixed-citation><mixed-citation xml:lang="en">Fedorenko OY, Loonen AJ, Lang F, Toshchakova VA, Boyarko EG, Semke AV, et al. Association study indicates a protective role of phosphatidylinositol-4phosphate-5-kinase against tardive dyskinesia. Int J Neuropsychopharmacol. 2014;18(6). pii: pyu098. doi: 10.1093/ijnp/pyu098.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J. Alzheimer’s presenilin 1 mutations impair kinesinbased axonal transports. J. Neurosci. 2003;23:4499–4508.</mixed-citation><mixed-citation xml:lang="en">Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J. Alzheimer’s presenilin 1 mutations impair kinesinbased axonal transports. J. Neurosci. 2003;23:4499–4508.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Psychosis Endophenotypes International Consortium, Wellcome Trust Case-Control Consortium, Bramon E, Pirinen M, Strange A, Lin K, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biol. Psychiatry 2014;75(5):386–97. doi: 10.1016/j.biopsych.2013.03.033.</mixed-citation><mixed-citation xml:lang="en">Psychosis Endophenotypes International Consortium, Wellcome Trust Case-Control Consortium, Bramon E, Pirinen M, Strange A, Lin K, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biol. Psychiatry 2014;75(5):386–97. doi: 10.1016/j.biopsych.2013.03.033.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
